Stage III Cutaneous Melanoma AJCC v7 Completed Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0091046 (Stage III Cutaneous Melanoma AJCC v7)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01807182
Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic MelanomaTreatment